Lauren A. Baldassarre, MD, FACC
Associate Professor of Medicine (Cardiovascular Medicine)Cards
About
Research
Publications
2024
Artificial intelligence applied to electrocardiographic images for the risk stratification of cancer therapeutics-related cardiac dysfunction
Oikonomou E, Sangha V, Dhingra L, Aminorroaya A, Coppi A, Krumholz H, Baldassarre L, Khera R. Artificial intelligence applied to electrocardiographic images for the risk stratification of cancer therapeutics-related cardiac dysfunction. European Heart Journal 2024, 45: ehae666.3190. DOI: 10.1093/eurheartj/ehae666.3190.Peer-Reviewed Original ResearchCancer therapeutics-related cardiac dysfunctionImmune checkpoint inhibitorsGlobal longitudinal strainLeft ventricular systolic dysfunctionNon-Hodgkin's lymphomaCardiac dysfunctionAI-ECGNegative control analysesAssociated with higher incidenceVentricular systolic dysfunctionCohort of patientsRisk stratification strategiesCheckpoint inhibitorsTrastuzumab exposureSystolic dysfunctionRisk stratificationBreast cancerRisk biomarkersSecondary outcomesLongitudinal strainStratification strategiesTrastuzumabPatientsHigher incidenceAnthracyclinesRetraction notice to Gedatolisib Associated Acute Myocarditis in a Patient With Breast Adenocarcinoma J Am Coll Cardiol. 2024;83(13 Suppl):3575.
Shen M, Khattab M, Akintoye E, Baldassarre L, Kwan J. Retraction notice to Gedatolisib Associated Acute Myocarditis in a Patient With Breast Adenocarcinoma J Am Coll Cardiol. 2024;83(13 Suppl):3575. Journal Of The American College Of Cardiology 2024, 84: 1683. PMID: 39415403, DOI: 10.1016/j.jacc.2024.09.017.Peer-Reviewed Original ResearchArtificial Intelligence-Enhanced Risk Stratification of Cancer Therapeutics-Related Cardiac Dysfunction Using Electrocardiographic Images.
Oikonomou E, Sangha V, Dhingra L, Aminorroaya A, Coppi A, Krumholz H, Baldassarre L, Khera R. Artificial Intelligence-Enhanced Risk Stratification of Cancer Therapeutics-Related Cardiac Dysfunction Using Electrocardiographic Images. Circulation Cardiovascular Quality And Outcomes 2024 PMID: 39221857, DOI: 10.1161/circoutcomes.124.011504.Peer-Reviewed Original ResearchCancer therapeutics-related cardiac dysfunctionGlobal longitudinal strainLeft ventricular systolic dysfunctionCardiac dysfunctionBreast cancerNon-Hodgkin lymphoma therapyNon-Hodgkin's lymphomaVentricular systolic dysfunctionAssociated with worse global longitudinal strainRisk stratification strategiesHigh-risk groupMonths post-treatmentPost hoc analysisElectrocardiographic (ECGTrastuzumab exposureLymphoma therapySystolic dysfunctionAI-ECGBefore treatmentRisk biomarkersLongitudinal strainLow riskStratification strategiesHigher incidencePositive screenArtificial intelligence and machine learning for cardiovascular computed tomography (CCT): A white paper of the society of cardiovascular computed tomography (SCCT)
Williams M, Weir-McCall J, Baldassarre L, De Cecco C, Choi A, Dey D, Dweck M, Isgum I, Kolossvary M, Leipsic J, Lin A, Lu M, Motwani M, Nieman K, Shaw L, van Assen M, Nicol E. Artificial intelligence and machine learning for cardiovascular computed tomography (CCT): A white paper of the society of cardiovascular computed tomography (SCCT). Journal Of Cardiovascular Computed Tomography 2024 PMID: 39214777, DOI: 10.1016/j.jcct.2024.08.003.Peer-Reviewed Original ResearchRemoved: “Kiosk 8Q-FA-03—Gedatolisib Associated Acute Myocarditis in a Patient with Breast Adenocarcinoma” [Journal of Cardiovascular Magnetic Resonance 26 (2024) 100856]
Khattab M, Kwan J, Alkhatib D, Shen M, Desai S, Akintoye E, Huber S, Baldassarre L. Removed: “Kiosk 8Q-FA-03—Gedatolisib Associated Acute Myocarditis in a Patient with Breast Adenocarcinoma” [Journal of Cardiovascular Magnetic Resonance 26 (2024) 100856]. Journal Of Cardiovascular Magnetic Resonance 2024, 101084. PMID: 39181776, DOI: 10.1016/j.jocmr.2024.101084.Peer-Reviewed Original ResearchAdverse social determinants of health elevate uncontrolled hypertension risk: a cardio-oncology prospective cohort study
Nain P, Stabellini N, Makram O, Rast J, Yerraguntla S, Gopu G, Bhave A, Seth L, Patel V, Jiang S, Malik S, Shetewi A, Montero A, Cullen J, Agarwal N, Wang X, Ky B, Baldassarre L, Weintraub N, Harris R, Guha A. Adverse social determinants of health elevate uncontrolled hypertension risk: a cardio-oncology prospective cohort study. JNCI Cancer Spectrum 2024, 8: pkae064. PMID: 39115393, PMCID: PMC11368120, DOI: 10.1093/jncics/pkae064.Peer-Reviewed Original ResearchSocial determinants of healthSocial determinants of health scoreSocial determinantsAdverse SDHImpact of social determinants of healthUncontrolled hypertensionAdverse social determinantsDeterminants of healthRisk of uncontrolled hypertensionProspective cohort studyCardio-oncology clinicCancer patientsBlood pressure readingsHypertension riskHypertension controlCohort studySocial isolationUrban residentsClinic blood pressure readingsControlled hypertensionIncreased riskProspective study patientsCox regressionCardio-oncologyHealthKiosk 8Q-FA-03 Gedatolisib Associated Acute Myocarditis in a Patient with Breast Adenocarcinoma
Khattab M, Kwan J, Alkhatib D, Shen M, Desai S, Akintoye E, Huber S, Baldassarre L. Kiosk 8Q-FA-03 Gedatolisib Associated Acute Myocarditis in a Patient with Breast Adenocarcinoma. Journal Of Cardiovascular Magnetic Resonance 2024, 26: 100856. PMID: 39155091, DOI: 10.1016/j.jocmr.2024.100856.Peer-Reviewed Original ResearchGEDATOLISIB ASSOCIATED ACUTE MYOCARDITIS IN A PATIENT WITH BREAST CANCER
Shen M, Khattab M, Akintoye E, Baldassarre L, Kwan J. GEDATOLISIB ASSOCIATED ACUTE MYOCARDITIS IN A PATIENT WITH BREAST CANCER. Journal Of The American College Of Cardiology 2024, 83: 3575. PMID: 39327001, DOI: 10.1016/s0735-1097(24)05565-7.Peer-Reviewed Original ResearchMultimodality Cardiac Imaging and the Imaging Workforce in the United States: Diversity, Disparities, and Future Directions
Bullock-Palmer R, Rosario K, Douglas P, Hahn R, Lang R, Chareonthaitawee P, Srichai M, Ordovas K, Baldassarre L, Burroughs M, Henderson C, Woodard P, Pressoir K, Swaminathan M, Blankstein R, Daubert M. Multimodality Cardiac Imaging and the Imaging Workforce in the United States: Diversity, Disparities, and Future Directions. Circulation Cardiovascular Imaging 2024, 17: e016409. PMID: 38377238, DOI: 10.1161/circimaging.123.016409.Peer-Reviewed Original ResearchKiosk 5R-TA-04 Comprehensive Characterization of Cardiac, Skeletal and Diaphragmatic Myotoxicity Using CMR in Patients with Immune Checkpoint Inhibitor Therapy and Relation to Outcomes
Charpentier E, boussouar S, Bretagne M, Bouazizi K, Kachenoura N, Nguyen L, Pasi N, Edhery S, allenbach Y, Similowski T, Kerneis M, Baldassarre L, Salem J, Redheuil A. Kiosk 5R-TA-04 Comprehensive Characterization of Cardiac, Skeletal and Diaphragmatic Myotoxicity Using CMR in Patients with Immune Checkpoint Inhibitor Therapy and Relation to Outcomes. Journal Of Cardiovascular Magnetic Resonance 2024, 26: 100680. DOI: 10.1016/j.jocmr.2024.100680.Peer-Reviewed Original Research
Clinical Trials
Current Trials
Advanced Cardiovascular Magnetic Resonance for Detection of Programmed Cell Death Protein-1 Deficient Myocarditis
HIC ID2000023943RolePrincipal InvestigatorPrimary Completion Date10/29/2024Recruiting Participants
Academic Achievements & Community Involvement
Clinical Care
Overview
Lauren Baldassarre, MD, is a cardiologist at Yale Medicine and director of the Cardio-Oncology Program at the Yale Cancer Center.
Cardio-oncology is a relatively new field that helps patients manage the cardiac side effects of therapies they’re receiving for cancer treatment (such as chemotherapy, radiation and immunotherapy). The goal of the cardio-oncology program is to diagnose and treat those side effects as early as possible.
Dr. Baldassarre first became interested in cardio-oncology during her cardiology fellowship, and she decided to pursue and complete an additional year of fellowship training at the Memorial Sloan Kettering Cancer Center in New York City. That fellowship focused on advanced cardiac imaging with cardiac MRI and caring for cancer patients with cardiac questions or complications. It was a way for Dr. Baldassarre to combine her interests in women’s heart disease and cardiac imaging, and introduced her to the field of cardio-oncology. In 2013, she arrived at Yale Medicine and became the director of the cardio-oncology program in 2015.
As the director, Dr. Baldassarre’s goals have been to offer care to any patient who might benefit from cardiovascular risk assessment and monitoring not only at the main hospital, but also at Yale Medicine satellite sites, and to expand research and clinical trials that investigate ways to diagnose cardiac complications from cancer earlier.
When meeting with new patients, Dr. Baldassarre takes a thorough history and physical and completes a cardiovascular risk assessment based on the type of cancer therapy they will be receiving. Patients can also expect to undergo some cardiac imaging as part of that risk assessment.
“I really hope to be able to put patients at ease,” says Dr. Baldassarre. “I know that patients are concerned especially when they’re going through so much already.” She walks them through established monitoring and treatments protocols, which may be used to prevent complications or treat them, if they do arise.
In addition to seeing patients, Dr. Baldassarre researches the cardiac side effects of immunotherapy, one of the most promising therapies for cancer. She is also an associate professor (cardiology) at Yale Medicine.
Clinical Specialties
Fact Sheets
CT Scan for Coronary Artery Disease
Learn More on Yale MedicineHeart Disease in Women
Learn More on Yale MedicineChronic Total Occlusion (CTO)
Learn More on Yale MedicineCoronary Artery Disease (CAD)
Learn More on Yale Medicine
Board Certifications
Cardiovascular Computed Tomography
- Certification Organization
- AB of Nuclear Cardiology
- Original Certification Date
- 2016
Cardiovascular Disease
- Certification Organization
- AB of Internal Medicine
- Original Certification Date
- 2012
Cardiovascular Computed Tomography
- Certification Organization
- Certification Board of Cardiovascular Computed Tomography
- Original Certification Date
- 2012
Yale Medicine News
News & Links
News
- September 18, 2024
Drs. Gallegos and Akintoye Named New Leaders of Yale’s Advanced Cardiac Imaging Fellowship Program
- July 24, 2024
Yale Department of Internal Medicine Faculty Promotions and Appointments (July 2024)
- April 01, 2024
Yale Faculty Present Groundbreaking Clinical Research at the 2024 American College of Cardiology Scientific Sessions
- June 09, 2023
Five faculty members receive Innovative Project Award for sarcoidosis research